Parameter
| Biomarker | Ki-67 | Full name | Ki-67 Protein | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis, Risk Stratification |
| Disease | Epilepsy | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Tumor Tissue (Immunohistochemistry) | ||
| Pathobiological Mechanisms | Reflects tumor proliferation activity; higher expression indicates more significant intracerebral microenvironment disorder and increased epilepsy onset risk. | ||||
| Clinical Availability Status | Under clinical validation | ||||
| Notes and Dynamics | In WHO grade II glioma patients with Ki-67 index > 5%, the postoperative epilepsy recurrence risk is increased by 2 times. | ||||